News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
850,802 Results
Type
Article (86605)
Company Profile (654)
Press Release (763542)
Multimedia
Podcasts (143)
Webinars (19)
Section
Business (232706)
Career Advice (4131)
Deals (39757)
Drug Delivery (126)
Drug Development (91012)
Employer Resources (198)
FDA (18135)
Job Trends (17360)
News (396529)
Policy (39758)
Tag
Academia (3000)
Academic (1)
Accelerated approval (9)
Adcomms (28)
Allergies (103)
Alliances (56957)
ALS (114)
Alzheimer's disease (1549)
Antibody-drug conjugate (ADC) (178)
Approvals (18101)
Artificial intelligence (358)
Autoimmune disease (34)
Automation (18)
Bankruptcy (402)
Best Places to Work (12618)
BIOSECURE Act (22)
Biosimilars (132)
Biotechnology (448)
Bladder cancer (91)
Brain cancer (39)
Breast cancer (369)
Cancer (2929)
Cardiovascular disease (229)
Career advice (3539)
Career pathing (34)
CAR-T (203)
CDC (33)
Cell therapy (549)
Cervical cancer (23)
Clinical research (74123)
Collaboration (1084)
Company closure (3)
Compensation (678)
Complete response letters (29)
COVID-19 (2892)
CRISPR (66)
C-suite (331)
Cystic fibrosis (117)
Data (2967)
Decentralized trials (2)
Denatured (50)
Depression (71)
Diabetes (342)
Diagnostics (6954)
Digital health (22)
Diversity (9)
Diversity, equity & inclusion (49)
Drug discovery (150)
Drug pricing (127)
Drug shortages (23)
Duchenne muscular dystrophy (127)
Earnings (97293)
Editorial (44)
Employer branding (25)
Employer resources (169)
Events (131203)
Executive appointments (895)
FDA (19790)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (972)
Gene editing (146)
Generative AI (31)
Gene therapy (423)
GLP-1 (870)
Government (5204)
Grass and pollen (6)
Guidances (178)
Healthcare (20874)
Huntington's disease (32)
IgA nephropathy (43)
Immunology and inflammation (168)
Immuno-oncology (9)
Indications (40)
Infectious disease (3063)
Inflammatory bowel disease (163)
Inflation Reduction Act (13)
Influenza (66)
Intellectual property (119)
Interviews (813)
IPO (17890)
IRA (45)
Job creations (5193)
Job search strategy (2863)
Kidney cancer (14)
Labor market (56)
Layoffs (580)
Leadership (25)
Legal (10106)
Liver cancer (83)
Lung cancer (410)
Lymphoma (205)
Machine learning (10)
Management (65)
Manufacturing (405)
MASH (96)
Medical device (14677)
Medtech (14682)
Mergers & acquisitions (22544)
Metabolic disorders (881)
Multiple sclerosis (101)
NASH (23)
Neurodegenerative disease (135)
Neuropsychiatric disorders (37)
Neuroscience (2264)
NextGen: Class of 2025 (7672)
Non-profit (5085)
Now hiring (48)
Obesity (437)
Opinion (286)
Ovarian cancer (99)
Pain (112)
Pancreatic cancer (121)
Parkinson's disease (194)
Partnered (24)
Patents (305)
Patient recruitment (157)
Peanut (55)
People (65616)
Pharmaceutical (133)
Pharmacy benefit managers (18)
Phase I (22899)
Phase II (32207)
Phase III (24225)
Pipeline (1632)
Policy (210)
Postmarket research (3546)
Preclinical (10333)
Press Release (72)
Prostate cancer (143)
Psychedelics (42)
Radiopharmaceuticals (275)
Rare diseases (497)
Real estate (7402)
Recruiting (76)
Regulatory (27027)
Reports (61)
Research institute (2657)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (9)
RSV (51)
Schizophrenia (93)
Series A (168)
Series B (111)
Service/supplier (27)
Sickle cell disease (64)
Special edition (22)
Spinal muscular atrophy (165)
Sponsored (35)
Startups (4300)
State (2)
Stomach cancer (15)
Supply chain (69)
Tariffs (56)
The Weekly (91)
Vaccines (872)
Venture capital (54)
Weight loss (289)
Women's health (49)
Worklife (20)
Date
Last 7 days (332)
Last 30 days (1961)
Last 365 days (32523)
2025 (17007)
2024 (37473)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (69)
Alaska (7)
Arizona (274)
Arkansas (14)
Asia (50485)
Australia (8873)
California (7587)
Canada (2324)
China (714)
Colorado (319)
Connecticut (325)
Delaware (194)
Europe (115741)
Florida (1111)
Georgia (243)
Hawaii (2)
Idaho (66)
Illinois (681)
India (31)
Indiana (375)
Iowa (18)
Japan (231)
Kansas (115)
Kentucky (30)
Louisiana (16)
Maine (73)
Maryland (1073)
Massachusetts (5827)
Michigan (266)
Minnesota (471)
Mississippi (3)
Missouri (99)
Montana (31)
Nebraska (26)
Nevada (81)
New Hampshire (72)
New Jersey (2113)
New Mexico (30)
New York (2113)
North Carolina (1218)
North Dakota (10)
Northern California (3266)
Ohio (241)
Oklahoma (15)
Oregon (46)
Pennsylvania (1604)
Puerto Rico (17)
Rhode Island (39)
South America (1653)
South Carolina (35)
South Dakota (1)
Southern California (2811)
Tennessee (117)
Texas (1141)
United States (28475)
Utah (227)
Virginia (200)
Washington D.C. (71)
Washington State (663)
West Virginia (4)
Wisconsin (80)
850,802 Results for "lotus bio technologies development corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Lotus Bio-Technology Development Corp, Inc. Initiates Company Name Change
Lotus Bio-Technology Development Corp. (OTC:LBTD) is excited to announce today that the company has begun the process of changing its name from Lotus Bio-Technology Development Corp. to Boomerang Corporation.
August 16, 2022
·
2 min read
Press Releases
MustGrow Biologics Corp. Announces Results of Shareholder Meeting
June 27, 2025
·
4 min read
Press Releases
Barinthus Bio Reports First Quarter 2025 Financial Results and Updates on Corporate Developments
May 7, 2025
·
14 min read
Press Releases
BioSig Enters into an LOI to Merge with Streamex Exchange Corp.
May 6, 2025
·
4 min read
Collaboration
Partner-Seeking Biotechs Find Plenty of Hands To Shake as BIO2025 Kicks Off
At a satellite kickoff event to the annual BIO meeting, investment bankers and VCs gave reasons for optimism amid a ‘volatile’ period for the industry.
June 16, 2025
·
2 min read
·
Jef Akst
Business
Lotus Bio-Technology Development Corp, Inc , Announces Resignation of Director and Surrendering of 150,000,000 Common Shares to Treasury.
Lotus Bio-Technology Development Corp. (OTC: LBTD) announced today that Zoltan Nagy has resigned as a board member of the Board of Directors effective August 3rd , 2022.
August 16, 2022
·
2 min read
Press Releases
Upstream Bio Appoints Stacy Price as Chief Technology Officer
May 20, 2025
·
6 min read
Sponsored
Taipei City Government Partners With Six Biotech Companies to Showcase at BIO International Convention 2025
The 2025 BIO International Convention (BIO2025), the world’s largest annual biotech event, will take place from June 16 to 19 (U.S. time) at the Boston Convention & Exhibition Center. This year, Taipei City Government is partnering with six Taipei-based biotech companies, including PanCAD.ai Co., Ltd., Instant NanoBiosensors Co., Ltd., Bened Biomedical Co., Ltd., Cancer Free Biotech Ltd., Xantho Biotechnology Co., Ltd., and Energenesis Biomedical Co., Ltd., to showcase their innovations at the Taiwan Pavilion (Booth #1645) in the Taipei Exhibition Area.
June 16, 2025
·
5 min read
Press Releases
LENZ Therapeutics and Lotus Pharmaceutical Announce Exclusive License and Commercialization Agreement for LNZ100 in the Republic of Korea and Southeast Asia
May 12, 2025
·
4 min read
Press Releases
Bio-Rad Offers to Acquire Digital PCR Developer Stilla Technologies
February 14, 2025
·
4 min read
1 of 85,081
Next
